Related Experiment Videos
Four additional cases of trisomy 14 as the sole anomaly in various haematological malignancies
A Brizard1, F Guilhot, P Babin
1Départment d'Hématologie et Oncologie Médicale, Hôpital Jean Bernard, Poitiers, France.
Leukemia Research
|January 1, 1992
Abstract:
We report on four cases of trisomy 14 as the sole anomaly. Three cases were myelodysplastic syndromes and one was a non-Hodgkin's lymphoma. This anomaly is mainly in myeloid disorders and still remains to be well documented. On the other hand, we show this anomaly to be also a non-random anomaly in lymphoproliferative disorders.
Insights
Trisomy 14, a chromosomal anomaly, was observed as the sole abnormality in three myelodysplastic syndromes and one non-Hodgkin
Area of Science:
- Cytogenetics
- Hematology
- Oncology
Background:
- Trisomy 14 is a chromosomal abnormality.
- Its role in myeloid and lymphoproliferative disorders requires further documentation.
- This study investigates trisomy 14 as the sole anomaly in hematologic malignancies.
Observation:
- Four cases presented trisomy 14 as the only chromosomal abnormality.
- Three cases involved myelodysplastic syndromes.
- One case was diagnosed with non-Hodgkin's lymphoma.
Findings:
- Trisomy 14 is predominantly associated with myeloid disorders.
- The anomaly was found to be non-random in lymphoproliferative disorders.
- This suggests a potential role in lymphomagenesis.
Implications:
- Highlights the significance of trisomy 14 in hematologic malignancies.
- Suggests further research into the pathogenetic mechanisms of trisomy 14 in lymphoid neoplasms.
- Contributes to understanding chromosomal abnormalities in cancer development.